Product Information: Deltyba®
Active Substance: Delamanid
Prescription Only Medicine
menu
You are about to leave the website of Otsuka Novel Products GmbH and view the content of an external website. Otsuka Novel Products GmbH cannot be held responsible for the content of external websites.
Active Substance: Delamanid
Prescription Only Medicine
For Healthcare Professionals:
Summary of Product Characteristics (German):
Deltyba 50 mg film-coated tablets (PDF)
For Patients:
Patient Information Leaflet (German):
Deltyba 50 mg film-coated tablets (PDF)
For Healthcare Professionals:
Summary of Product Characteristics (Estonian):
Deltyba 50 mg film-coated tablets (PDF)
For Patients:
Patient Information Leaflet (Estonian):
Deltyba 50 mg film-coated tablets (PDF)
For Healthcare Professionals:
Summary of Product Characteristics (French):
Deltyba 50 mg film-coated tablets (PDF)
For Patients:
Patient Information Leaflet (French):
Deltyba 50 mg film-coated tablets (PDF)
For Healthcare Professionals:
Summary of Product Characteristics (German):
Deltyba 50 mg film-coated tablets (PDF)
For Patients:
Patient Information Leaflet (German):
Deltyba 50 mg film-coated tablets (PDF)
For Healthcare Professionals:
Summary of Product Characteristics (Italian):
Deltyba 50 mg film-coated tablets (PDF)
For Patients:
Patient Information Leaflet (Italian):
Deltyba 50 mg film-coated tablets (PDF)
For Healthcare Professionals:
Summary of Product Characteristics (Latvian):
Deltyba 50 mg film-coated tablets (PDF)
For Patients:
Patient Information Leaflet (Latvian):
Deltyba 50 mg film-coated tablets (PDF)
For Healthcare Professionals:
Summary of Product Characteristics (Lithuanian):
Deltyba 50 mg film-coated tablets (PDF)
For Patients:
Patient Information Leaflet (Lithuanian):
Deltyba 50 mg film-coated tablets (PDF)
For Healthcare Professionals / Voor zorgverleners:
Summary of Product Characteristics / Samenvatting van de productkenmerken
Deltyba 50 mg film-coated tablets / Deltyba 50 mg filmomhulde tabletten (PDF)
Additional risk minimisation material / Additioneel risicominimalisatiemateriaal:
Deltyba additioneel risicominimalisatiemateriaal voor zorgverleners (PDF)
For patients / Voor de patiënt
Patient Information Leaflet / Bijsluiter: informatie voor de patiënt
Deltyba 50 mg film-coated tablets / Deltyba 50 mg filmomhulde tabletten (PDF)
Additional risk minimisation material / Additioneel risicominimalisatiemateriaal
Deltyba additioneel risicominimalisatiemateriaal voor de patiënt (PDF)
For Healthcare Professionals:
Summary of Product Characteristics (Romanian):
Deltyba 50 mg film-coated tablets (PDF)
For Patients:
Patient Information Leaflet (Romanian):
Deltyba 50 mg film-coated tablets (PDF)
For Healthcare Professionals:
Summary of Product Characteristics (Spanish):
Deltyba 50 mg film-coated tablets (PDF)
For Patients:
Patient Information Leaflet (Spanish):
Deltyba 50 mg film-coated tablets (PDF)
Information current as of 30-12-2020
Reference ONP-COP-2000001